TT4 Rapid Quantitative Test-The Biotime Total Thyroxine Rapid Quantitative Test is intended to quantify the concentration of total thyroxine in human serum or plasma on Biotime FIA Analyzer by fluorescent immunoassay. The test is used as an aid detection of thyroid gland disease,25 - India CDSCO Medical Device Registration

TT4 Rapid Quantitative Test-The Biotime Total Thyroxine Rapid Quantitative Test is intended to quantify the concentration of total thyroxine in human serum or plasma on Biotime FIA Analyzer by fluorescent immunoassay. The test is used as an aid detection of thyroid gland disease,25 is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000035_4d12d7624e1efe2591e3cdcb6f184a11_fcebdd83cabb64f0d149231a9e1b1317. This device is marketed under the brand name Immunoglobulin E. The license holder is DIYA SCIENTIFIC, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.